Belemjian Mark E MD is categorized under Pediatricians in East Longmeadow, MA and active since 1988.
Belemjian Mark E MD was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pediatricians business, which does work in the B2C market, and is classified as a Pediatricians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mark Belemjian at the company’s single location by writing to 294 North Main St # 101, East Longmeadow, Massachusetts MA 01028 or by phoning (413) 525-1870. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Belemjian Mark E MD |
| Contact Person: | Mark Belemjian |
| Address: | 294 North Main St # 101, East Longmeadow, Massachusetts 01028 |
| Phone Number: | (413) 525-1870 |
| Website Address: | pediatricservices.medem.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pediatricians |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Belemjian Mark E MD was started in 1988 to provide professional Pediatricians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Belemjian for inquiries that concern Belemjian Mark E MD by calling the company number (413) 525-1870, as your correspondence is most welcome. Additionally, the physical location of the single location of Belemjian Mark E MD can be found at the coordinates 42.07542,-72.52124 as well as the street address 294 North Main St # 101 in East Longmeadow, Massachusetts 01028.
For its online presence, you may visit Belemjian Mark E MD’s website at pediatricservices.medem.com and engage with its social media outlets through on Twitter and on Facebook.